Analysts’ Weekly Ratings Updates for Smith & Nephew (SN)

Analysts’ Weekly Ratings Updates for Smith & Nephew (SN)

A number of research firms have changed their ratings and price targets for Smith & Nephew (LON: SN):

2/11/2019 – Smith & Nephew had its price target raised by analysts at JPMorgan Chase & Co. from GBX 1,477 ($19.30) to GBX 1,516 ($19.81). They now have a “neutral” rating on the stock.

2/11/2019 – Smith & Nephew had its price target raised by analysts at Goldman Sachs Group Inc from GBX 1,400 ($18.29) to GBX 1,440 ($18.82). They now have a “neutral” rating on the stock.

2/8/2019 – Smith & Nephew was downgraded by analysts at BNP Paribas to a “neutral” rating. They now have a GBX 1,525 ($19.93) price target on the stock, up previously from GBX 1,475 ($19.27).

2/8/2019 – Smith & Nephew had its price target raised by analysts at Credit Suisse Group AG from GBX 1,330 ($17.38) to GBX 1,390 ($18.16). They now have a “neutral” rating on the stock.

2/8/2019 – Smith & Nephew had its “hold” rating reaffirmed by analysts at Deutsche Bank AG.

1/28/2019 – Smith & Nephew had its price target raised by analysts at UBS Group AG from GBX 1,340 ($17.51) to GBX 1,390 ($18.16). They now have a “neutral” rating on the stock.

1/8/2019 – Smith & Nephew had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a GBX 1,477 ($19.30) price target on the stock.

1/2/2019 – Smith & Nephew was downgraded by analysts at JPMorgan Chase & Co. to a “neutral” rating. They now have a GBX 1,477 ($19.30) price target on the stock.

Shares of LON SN traded down GBX 45.50 ($0.59) during mid-day trading on Monday, reaching GBX 1,469.50 ($19.20). The company had a trading volume of 3,928,630 shares, compared to its average volume of 3,250,000. Smith & Nephew plc has a 1-year low of GBX 1,173 ($15.33) and a 1-year high of GBX 1,442 ($18.84).

The business also recently announced a dividend, which will be paid on Wednesday, May 8th. Investors of record on Thursday, April 4th will be issued a $0.22 dividend. This represents a dividend yield of 1.1%. This is a boost from Smith & Nephew’s previous dividend of $0.14. The ex-dividend date of this dividend is Thursday, April 4th.

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Featured Story: How Do You Make Money With Penny Stocks?

Related posts

Leave a Comment